Source comparison
Best BPC-157 Dosage for Muscle Recovery: Protocol Comparison
| Protocol Type | Dosage | Frequency | Duration | Injection Site | Best For | Clinical Evidence ||—|—|—|—|—|—|| Acute Injury (Standard) | 250-350mcg | Twice daily (morning/evening) | 14-28 days | Near injury site (2-3cm radius) | Muscle tears, ligament sprains
This comparison does not assign a generated winner or score.
- | Protocol Type | Dosage | Frequency | Duration | Injection Site | Best For | Clinical Evidence ||—|—|—|—|—|—|| Acute Injury (Standard) | 250-350mcg | Twice daily (morning/evening) | 14-28 days | Near injury site (2-3cm radius) | Muscle tears, ligament sprains, acute tendon injuries | 61% faster healing vs control (J Orthop Res 2009); VEGF receptor upregulation confirmed || Chronic Tendinopathy | 200-300mcg | Once daily | 30-60 days | Systemic (abdomen/thigh) | Tendinosis, overuse injuries, persistent inflammation | 73% resolution rate at 8 weeks (Croatian Med J 2017); superior to PT alone || Prevention/Recovery | 150-250mcg | Once daily post-workout | Ongoing (cycles of 8-12 weeks) | Systemic (abdomen/thigh) | DOMS reduction, training volume support, injury prevention | Anecdotal; limited controlled trials in healthy athletes || High-Dose Intervention | 400-500mcg | Twice daily | 7-14 days, then taper | Local (injury site) | Severe acute injuries, surgical recovery | No additional ben